Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
9491 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Proteasome inhibitor subunit 1 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
PSMF1 |
SynonymsGene synonyms aliases
|
PI31 |
ChromosomeChromosome number
|
20 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
20p13 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a protein that inhibits the activation of the proteasome by the 11S and 19S regulators. Alternative transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008] |
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000165 |
Process |
MAPK cascade |
TAS |
|
GO:0000209 |
Process |
Protein polyubiquitination |
TAS |
|
GO:0002223 |
Process |
Stimulatory C-type lectin receptor signaling pathway |
TAS |
|
GO:0002479 |
Process |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
TAS |
|
GO:0004866 |
Function |
Endopeptidase inhibitor activity |
NAS |
10764772 |
GO:0005515 |
Function |
Protein binding |
IPI |
16000308, 16713569, 19060904, 25416956, 25910212, 26496610, 28514442, 31515488, 32296183, 32814053 |
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005783 |
Component |
Endoplasmic reticulum |
IDA |
18495667 |
GO:0005829 |
Component |
Cytosol |
IDA |
18495667 |
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005839 |
Component |
Proteasome core complex |
NAS |
10764772 |
GO:0006511 |
Process |
Ubiquitin-dependent protein catabolic process |
IBA |
21873635 |
GO:0006511 |
Process |
Ubiquitin-dependent protein catabolic process |
IDA |
10764772 |
GO:0006521 |
Process |
Regulation of cellular amino acid metabolic process |
TAS |
|
GO:0010951 |
Process |
Negative regulation of endopeptidase activity |
IEA |
|
GO:0010972 |
Process |
Negative regulation of G2/M transition of mitotic cell cycle |
TAS |
|
GO:0016020 |
Component |
Membrane |
HDA |
19946888 |
GO:0016579 |
Process |
Protein deubiquitination |
TAS |
|
GO:0031145 |
Process |
Anaphase-promoting complex-dependent catabolic process |
TAS |
|
GO:0031146 |
Process |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
TAS |
|
GO:0033209 |
Process |
Tumor necrosis factor-mediated signaling pathway |
TAS |
|
GO:0038061 |
Process |
NIK/NF-kappaB signaling |
TAS |
|
GO:0038095 |
Process |
Fc-epsilon receptor signaling pathway |
TAS |
|
GO:0042803 |
Function |
Protein homodimerization activity |
IDA |
18495667 |
GO:0043161 |
Process |
Proteasome-mediated ubiquitin-dependent protein catabolic process |
TAS |
|
GO:0043488 |
Process |
Regulation of mRNA stability |
TAS |
|
GO:0043687 |
Process |
Post-translational protein modification |
TAS |
|
GO:0046982 |
Function |
Protein heterodimerization activity |
IPI |
18495667 |
GO:0048471 |
Component |
Perinuclear region of cytoplasm |
IDA |
18495667 |
GO:0050852 |
Process |
T cell receptor signaling pathway |
TAS |
|
GO:0055085 |
Process |
Transmembrane transport |
TAS |
|
GO:0060071 |
Process |
Wnt signaling pathway, planar cell polarity pathway |
TAS |
|
GO:0061418 |
Process |
Regulation of transcription from RNA polymerase II promoter in response to hypoxia |
TAS |
|
GO:0070498 |
Process |
Interleukin-1-mediated signaling pathway |
TAS |
|
GO:0070628 |
Function |
Proteasome binding |
IDA |
10764772 |
GO:0090090 |
Process |
Negative regulation of canonical Wnt signaling pathway |
TAS |
|
GO:0090263 |
Process |
Positive regulation of canonical Wnt signaling pathway |
TAS |
|
GO:1901799 |
Process |
Negative regulation of proteasomal protein catabolic process |
IDA |
10764772 |
GO:1901990 |
Process |
Regulation of mitotic cell cycle phase transition |
TAS |
|
GO:1902036 |
Process |
Regulation of hematopoietic stem cell differentiation |
TAS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q92530 |
Protein name |
Proteasome inhibitor PI31 subunit (hPI31) |
Protein function |
Plays an important role in control of proteasome function. Inhibits the hydrolysis of protein and peptide substrates by the 20S proteasome. Also inhibits the activation of the proteasome by the proteasome regulatory proteins PA700 and PA28. |
PDB |
2VT8
,
4OUH
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF11566 |
PI31_Prot_N |
11 → 149 |
PI31 proteasome regulator N-terminal |
Family |
PF08577 |
PI31_Prot_C |
153 → 248 |
PI31 proteasome regulator |
Family |
|
Sequence |
|
Sequence length |
271 |
Interactions |
View interactions |